Wax Matrix Nicotinic Acid STUDIES

Highlights Open label study (n=101 men and women) Extended-release wax-matrix nicotinic acid promotes optimal LDL and HDL cholesterol balance Well tolerated with only 4% dropout rate (4/101) Summary This open...

Highlights 6-month blinded, crossover study (n=31 adults) Extended-release, wax-matrix nicotinic acid supports lipid and lipoprotein (apo-A1 and apo-B) metabolism Treatment reported to be well tolerated Summary This clinical study was...

Highlights Randomized, double-blind, placebo-controlled, cross-over trial (n=69 adults) Promotes optimal lipid and lipoprotein metabolism Effective dosage is 1,500 to 2,000 mg/day Low 5% dropout rate due to treatment intolerance Summary...

Highlights Randomized, double-blind, controlled trial (n=62 men) Therapeutic option to support lipid metabolism and cholesterol balance Typical effective dosage (1,500 mg/day) is well tolerated Summary This randomized, double-blind, controlled trial,...

Highlights Open-label, pilot study (40 men and women) Supports lipid metabolism and cerebrovascular tone/reactivity Effective dosage: 1,500 mg/day for 6 months Summary This open-label trial was designed to assess the...